Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model‐informed precision dosing trial simulations-Reference-Cited by-同舟云学术

Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model‐informed precision dosing trial simulations

Published:2022-02-15 Issue:4 Volume:15 Page:942-953
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Aljutayli Abdullah¹²,Thirion Daniel J. G.¹³,Bonnefois Guillaume⁴,Nekka Fahima³⁵⁶

Affiliation:

1. Faculty of Pharmacy Université de Montréal Montréal Quebec Canada

2. Department of Pharmaceutics Faculty of Pharmacy Qassim University Buraydah Saudi Arabia

3. Department of Pharmacy McGill University Health Center Montréal Quebec Canada

4. Certara Inc. Montréal Quebec Canada

5. Laboratoire de Pharmacométrie Faculté de Pharmacie Université de Montréal Montréal Quebec Canada

6. Centre de recherches mathématiques Université de Montréal Montréal Quebec Canada

Funder

Pfizer

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13210

Reference35 articles.

1. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

2. The Pharmacokinetic and Pharmacodynamic Properties of Vancomycin

3. Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing

4. A Canadian perspective on the revised 2020 ASHP–IDSA–PIDS–SIDP guidelines for vancomycin AUC‐based therapeutic drug monitoring for serious MRSA infections;Stewart JJ;Official J Assoc Med Microbiol Infect Dis Can,2021

5. A Model Averaging/Selection Approach Improves the Predictive Performance of Model‐Informed Precision Dosing: Vancomycin as a Case Study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automated calculation and reporting of vancomycin area under the concentration–time curve: a simplified single-trough concentration-based equation approach;Antimicrobial Agents and Chemotherapy;2024-08-28

2. Optimization of Vancomycin Initial Dosing Regimen in Neonates Using an Externally Evaluated Population Pharmacokinetic Model;Therapeutic Drug Monitoring;2024-06-06

3. Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?;European Journal of Drug Metabolism and Pharmacokinetics;2024-05-05

4. Model-informed precision dosing in vancomycin treatment;Frontiers in Pharmacology;2023-10-09

5. Model‐informed precision dosing of vancomycin for rapid achievement of target area under the concentration‐time curve: A simulation study;Clinical and Translational Science;2023-09-22